BIIB092
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BIIB092, covering 2020-12-21 to 2022-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease [Phase 2]